Barriers and facilitators to human papillomavirus vaccination among Chinese adolescent girls in Hong Kong: A qualitative-quantitative study by Chan, KKL et al.
Title
Barriers and facilitators to human papillomavirus vaccination
among Chinese adolescent girls in Hong Kong: A qualitative-
quantitative study
Author(s) Kwan, TTC; Chan, KKL; Yip, AMW; Tam, KF; Cheung, ANY;Young, PMC; Lee, PWH; Ngan, HYS
Citation Sexually Transmitted Infections, 2008, v. 84 n. 3, p. 227-232
Issued Date 2008
URL http://hdl.handle.net/10722/57408
Rights Creative Commons: Attribution 3.0 Hong Kong License
doi:10.1136/sti.2007.029363 
 2008;84;227-232; originally published online 6 Feb 2008; Sex Transm Inf
  
W H Lee and H Y S Ngan 
T T C Kwan, K K L Chan, A M W Yip, K F Tam, A N Y Cheung, P M C Young, P
  
 Hong Kong: a qualitativequantitative study
vaccination among Chinese adolescent girls in 
Barriers and facilitators to human papillomavirus
 http://sti.bmj.com/cgi/content/full/84/3/227
Updated information and services can be found at: 
 These include:
 References
  
 http://sti.bmj.com/cgi/content/full/84/3/227#BIBL
This article cites 10 articles, 2 of which can be accessed free at: 
Rapid responses
 http://sti.bmj.com/cgi/eletter-submit/84/3/227
You can respond to this article at: 
 service
Email alerting
the top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at
 Notes   
 http://journals.bmj.com/cgi/reprintform
To order reprints of this article go to: 
 http://journals.bmj.com/subscriptions/
 go to: Sexually Transmitted InfectionsTo subscribe to 
 on 31 May 2009 sti.bmj.comDownloaded from 
Barriers and facilitators to human papillomavirus
vaccination among Chinese adolescent girls in Hong
Kong: a qualitative–quantitative study
T T C Kwan,1 K K L Chan,1 A M W Yip,1 K F Tam,1 A N Y Cheung,2 P M C Young,3
P W H Lee,4 H Y S Ngan1
1 Division of Gynaecological
Oncology, Department of
Obstetrics and Gynaecology,
University of Hong Kong, Hong
Kong, China; 2 Department of
Pathology, University of Hong
Kong, Hong Kong, China;
3 School of Nursing, Hong Kong
Polytechnic University, Hong
Kong, China; 4 Division of Clinical
Health Psychology, Department
of Psychiatry, University of Hong
Kong, Hong Kong, China
Correspondence to:
Professor H Y S Ngan,
Department of Obstetrics and
Gynaecology, 6/F, Professorial
Block, Queen Mary Hospital,
Pokfulam, Hong Kong SAR,
China; hysngan@hkusua.hku.hk
Accepted 23 January 2008
Published Online First
6 February 2008
ABSTRACT
Objectives: To explore perceptions towards cervical
cancer, human papillomavirus (HPV) infection and HPV
vaccination and to identify factors affecting the accept-
ability of HPV vaccination among Chinese adolescent girls
in Hong Kong.
Methods: Six focus groups were conducted with Chinese
adolescent girls (median age 16 years, age range 13–20,
n = 64) in Hong Kong in April 2007. Thematic analysis
was employed to identify major themes related to cervical
cancer and HPV vaccination. A supplementary question-
naire was administered to all participants before and after
group discussion to assess their knowledge, attitudes and
intention to be vaccinated and to collect demographic
information.
Results: Participants’ knowledge on cervical cancer was
limited and HPV was largely unheard of. They had
difficulty understanding the mechanism linking cervical
cancer with HPV infection. Participants held a favourable
attitude towards HPV vaccination but the perceived timing
of vaccination varied. Barriers to vaccination include high
monetary cost, uncertain length of vaccine effectiveness,
low perceived risk of HPV infection, no immediate
perceived need of vaccination, anticipated family dis-
approval and fear of the pain of injection. Factors
conducive to vaccination include perceived family and
peer support and medical reassurance on safety and
efficacy of vaccine. The differences on knowledge,
attitudes, intention to be vaccinated now and willingness
to conform to significant others before and after the
discussion were statistically significant, with an increased
tendency towards favouring vaccination after the focus
group.
Conclusions: Participants favoured HPV vaccination
despite not feeling an immediate need to be vaccinated.
Interventions could focus on providing professional
information on HPV vaccination and raising adolescents’
perceived need to take preventive measures against HPV
infection.
Cervical cancer is a serious global disease afflicting
many women each year. It is the fifth most
common female cancer in Hong Kong, with an
age-standardised incidence rate of 9.5 per 100 000
women.1 Human papillomavirus (HPV) types 16
and 18, the strains accounting for nearly 70% of
cervical cancers worldwide,2 were among the most
common high-risk HPV identified in Hong Kong
women.3 The introduction of vaccines against HPV
16 and 18 can potentially lower the local cervical
cancer incidence. Coverage is crucial, however, and
vaccination acceptability in the target population
can greatly affect coverage. Despite adolescents
being the ideal target for HPV vaccination, their
views on the issue are little known. In Asia,
adolescents have a comparatively conservative
cultural upbringing. The mean age of first sex in
Hong Kong was 18.9 years (1996 data), which was
relatively late in comparison with other western
countries.4 Overall HPV prevalence is, however,
projected to rise as a result of increased sexual
openness and permissiveness among Hong Kong
adolescents.5 Data on the adolescents’ perceptions
of HPV vaccination are practically non-existent.
The objectives of this study were to explore
adolescent girls’ perceptions towards cervical can-
cer, HPV infection and HPV vaccination, and
factors affecting their acceptability of HPV vacci-
nation. Our findings would be useful in identifying
the need for HPV vaccination promotion among
young Chinese in Hong Kong, as well as those in
other parts of China and neighbouring Asian
countries that share a similar oriental cultural
heritage.
METHODS
Subjects
Healthy ethnic Chinese adolescent girls were
recruited from a community youth centre and a
secondary school using purposive sampling.
Adolescents attending the youth centre for recrea-
tional activities were invited to join the study by
the centre staff. In the participating school, form 2
and form 7 students (equivalent to UK form 2 and
lower 6th, respectively) were invited to participate
by their teachers. Intending participants were
given an information sheet about the study. A
signed parental consent was also obtained from all
participants.
Data collection
Qualitative research methods were deemed most
appropriate in exploring attitudes and beliefs that
are not previously or systematically known. In this
study, a qualitative–quantitative approach was
used in that focus group discussions were con-
ducted supplemented by a 27-item questionnaire
administered before and after the focus group to
detect changes. Groups of 10–12 girls were formed
according to age or educational level to increase
within-group homogeneity. Participants were
assured of the confidentiality and anonymity of
all data collected to encourage an open expression
of opinions. Each discussion lasted approximately
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one and a half hours and was led by two facilitators in the field
of gynaecological oncology or clinical health psychology. A
discussion guide was developed by the research team to
facilitate the flow of discussion. Based on findings from other
studies, the participants were expected to have little knowledge
about HPV infection and vaccination.6 7 Therefore, standardised
health information was provided intermittently as related to the
topic being discussed at the time (box 1). Information was given
after participants had shared their views or when they expressed
little knowledge or misconceptions on a specific issue.
The self-administered questionnaire was designed to assess:
(1) knowledge about cervical cancer and HPV infection; (2)
attitudes towards HPV vaccination measured by participants’
beliefs about the consequences of being vaccinated now;8 (3)
perceived support from family and friends; (4) intention to be
vaccinated and (5) willingness to conform to others’ decisions.
Sample questions are listed in box 2. Data on demographics
were also collected.
Travel reimbursement in the amount of $HK100 (or GB£6.25)
was given to each participant.
Box 1: Standardised information given to the participants
during the focus group
1. Cervical cancer is a prevalent female cancer. Each year
there are over 400 new cases in Hong Kong.
2. Cervical cancer mostly affects middle-aged or elderly
women. Recent trends show that the risk in younger
women has, however, increased slightly.
3. The chance of having cervical cancer is minimal in women
with no sexual experience.
4. Having multiple sexual partners increases the risk of cervical
cancer.
5. Other high-risk factors include smoking, sex at an early age,
long-term use of oral contraceptives and high parity.
6. Cervical cancer screening can effectively prevent cervical
cancer.
7. Sexually experienced women aged 25 years or above
should receive regular cervical cancer screening. A woman
is screened annually for the first 2 years. If results are
normal for both years, she can then be screened every
3 years afterwards.
8. There are many subtypes of HPV with various modes of
transmission. Different subtypes cause different diseases
such as skin diseases and genital diseases.
9. Some HPV are called high-risk HPV because they can cause
cancer. These HPV are mainly sexually transmitted. Most
people who become infected with high-risk HPV will not
have symptoms and most will clear the infections on their
own.
10. All women who have had sex may be at risk of being
infected by high-risk HPV.
11. Most HPV infections will disappear on their own.
12. Cervical cancer may occur if the cells in the cervix are
persistently infected by high-risk HPV.
13. Vaccination helps to raise the body’s ability to fight against
infections.
14. HPV vaccination can prevent cervical cancer.
15. HPV vaccination raises the body’s immunity against high-
risk HPV. As a result, the risk of cervical cells being infected
and subsequently developing into cervical cancer is
lowered.
16. The best time for HPV vaccination is before any experience
of sexual contact.
17. Based on research findings, the vaccines have been proved
effective for at least 5 years. They are generally safe.
Common side effects include soreness and swelling at the
injection site, fever and headache. These side effects are
usually mild in nature and short-lived. The cost of
vaccination is approximately $HK3000 (GB£187).
18. The vaccines are not 100% effective against cervical cancer.
Regular cervical cancer screening is necessary after HPV
vaccination.
Box 2: Sample items from the questionnaire assessing
participants’ knowledge on cervical cancer and HPV
infection and their attitudes towards HPV vaccination
c Knowledge on cervical cancer and HPV infection—15 items
(True/False/Don’t know answers). 1 score for each correct
answer and 0 score for each incorrect or ‘‘Don’t know’’
answer.* Examples:
– Cervical cancer is a disease mostly in older women, say
middle age or above.
– Cervical screening can effectively prevent cervical cancer.
– Having multiple sexual partners increases the chance of
getting cervical cancer.
– HPV infection causes cervical cancer.
– Anyone who has had sex before is at risk of HPV
infection.
– There is a vaccine to prevent HPV infection.
c Attitudes and perceived support from significant others
towards HPV vaccination—9 items measured by 4-point Likert
scale.* Examples:
– Do you think having this vaccine now is: bad, 1/
somewhat bad, 2/somewhat good, 3/good, 4.
– Do you think having this vaccine now is: unnecessary, 1/
somewhat unnecessary, 2/somewhat necessary, 3/
necessary, 4.
– Do you think having this vaccine now is: harmful, 1/
somewhat harmful, 2/somewhat beneficial, 3/beneficial,
4.
– Do you think your family thinks you should have this
vaccine: definitely no, 1/no, 2/yes, 3/definitely yes, 4.
c Intention to be vaccinated—1 item.
– If this vaccine is available for you now, how likely is it
that you will have it: very unlikely/unlikely/likely/very
likely.
c Willingness to conform to friends’ and family’s decisions—2
items.
– Imagine, some of your best friends have already had a
vaccination to prevent cervical cancer, how willing are
you also to have it: very unwilling/unwilling/willing/very
willing.
– Imagine, your mother or a close female family member
decides to take you to the doctor’s clinic for a vaccination
to prevent cervical cancer. How willing are you to comply:
very unwilling/unwilling/willing/very willing.
*The sum of all items in the section was obtained, with a higher
score indicating more knowledge or more positive attitude.
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Analyses
All focus group discussions were audiotaped and transcribed
verbatim. Data were sorted and organised. Thematic analysis
was used to code and categorise the data.9 Central and repetitive
themes were highlighted and conceptual similarities across
themes were noted.10 Data were compared across groups with
the aim of identifying differences as well as generating the most
representative summative categories. Findings were reviewed by
other research team members and core themes were highlighted
according to a consensus view. Conclusions formed are regarded
as verifiable with a clear data trail and are backed up by a
sufficiently robust dataset. At this stage, however, the
representativeness of the data is not explored or assumed.
Data from the questionnaire were analyzed by Spearman’s
rho correlations to explore associations among different
measures. Before and after focus group scores on knowledge
and attitudes were compared by Student’s paired t-tests.
Wilcoxon signed ranks tests were used to detect changes in
vaccination intention and willingness to conform. Data analysis
was performed using SPSS version 15.0 (SPSS Inc, Chicago,
Illinois, USA). A p value of less than 0.05 was considered
statistically significant.
RESULTS
Participants’ background and demographics
Sixty-four girls were recruited into six focus groups. There were
two groups of girls aged 13–14 years (A) (n = 20), three groups
aged 14–17 years (B) (n = 34) and one group aged 17–20 years
(C) (n = 10). Participants were grouped primarily by age
although a few girls were grouped to stay in the same group
with their peers upon their request. As a result, the age groups
overlapped. Participant characteristics are summarised in table 1.
When participants were asked about their ‘‘acceptable’’ age for
sex, 18 years old or above was deemed appropriate by most of
them.
Cervical cancer and HPV infection
All participants had heard of cervical cancer from the mass
media. Cervical cancer was regarded as a common disease of
grown-up women, which was of little concern to the
participants. Multiple probable causes of cervical cancer were
suggested by the participants, including lifestyle factors (eg,
unhealthy diet and poor personal hygiene), increased age,
heredity, environmental pollutants, stress and infection.
Sexual practices were regarded as being relevant, with particular
reference to promiscuity, having multiple sexual partners and a
high frequency of sex as risk factors. None of the participants
had, however, any realistic understanding of the mechanism
linking sex with cervical cancer.
No participant had any knowledge about HPV. A few girls
had heard of the lay term for genital warts. All they knew of
genital warts was that they were related to sex. Participants had
initial difficulties understanding that different HPV substrains
had different modes of transmission leading to different diseases
and the role of high-risk HPV in the development of cervical
cancer. Repeated clarifications by the facilitators were required.
On being told of the sexually transmitted nature of high-risk
HPV, the overwhelming response was a raised alertness and
caution towards sex. Many participants indicated that they
would think twice before having sex for fear of infection. One
participant in group C said ‘‘It (HPV) made the consequence of
sex more serious’’, whereas another in group A said ‘‘I would
only consider (sex) if he is worth it’’. Participants were surprised
while at the same time relieved to learn of the asymptomatic
and self-healing nature of most high-risk HPV infections. One
girl in group C asked ‘‘So, it (HPV) is not so scary after all…
why is it called high-risk?’’
HPV vaccination
Over half of the participants had heard of vaccination against
cervical cancer from television but no one could provide any
details about the vaccines nor the mode of action involved.
When asked for whom the vaccine was intended, the
participants could not clearly differentiate between the candi-
dates for cervical cancer screening with those for vaccination.
Some girls noted that those who frequently had sex needed it.
There were many arguments on whether the vaccine should be
given before or after having sex—reflecting confusion between a
prophylactic vaccine and a therapeutic one. Explanation on the
prophylactic nature of the current HPV vaccines had to be
given. Rather dubiously, one girl in group A claimed to have
received the vaccine at school and thus noted (erroneously) that
she no longer needed to attend cervical cancer screening in
future. The limitations of the current HPV vaccines and the
need to continue screening after vaccination were stressed by
the facilitators afterwards.
Questions were raised by the participants concerning the
vaccines’ costs, potential discomfort, adverse effects (in parti-
cular on fertility and appearance), the number of injections
required and duration of effectiveness. Before the issue of cost
was mentioned, the majority of the girls chose to be vaccinated
on condition that authoritative reassurances about safety and
efficacy were given. Those who refused provided reasons
including fear of pain, ‘‘still too young’’, no immediate perceived
need, no plan to have sex in the near future and the uncertain
duration of effectiveness of the vaccines. On being told that the
current data on effectiveness was available up to 5 years, most
participants regarded it as being ‘‘not long enough’’. After the
cost of vaccination was disclosed, the entire picture on
acceptability was altered. Many girls who previously expressed
Table 1 Participant characteristics (n = 64)
Characteristics
n (%) unless
otherwise stated
Age in years, median (range) 16 (13–20)
Parental marital status, n (%)
Married 51 (80)
Divorced/separated 6 (9)
Cohabiting 5 (8)
Widowed 2 (3)
Parental education, n (%)
Primary 18 (28)
Secondary 41 (64)
Tertiary 5 (8)
Monthly family income, in $HK* (%)
On government assistance 3 (5)
$10 000 and below 11 (17)
$10 001–15 000 18 (28)
$15 001–30 000 23 (36)
$30 001 and above 6 (9)
Missing data 3 (5)
Past experience with physical intimacy (participants may choose
more than one answer), n (%)
Holding hands—yes 42 (66)
Embracing—yes 34 (53)
Kissing—yes 23 (36)
Caressing—yes 7 (11)
Sexual intercourse—yes 5 (8)
*GB£ 1 = $HK16.01.
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a willingness to be vaccinated opted out. One girl in group C
stated ‘‘Where will I get the money for it (HPV vaccine)? At this
price, my family could not support me either’’. Another girl in
group A summarised the sentiments well, noting ‘‘I am too
young for the vaccine. If it is good only for 5 years, it will be a
waste of money to take it now because I am not going to start
sex in the next few years. I will wait till I am 18 years or older’’.
With regard to the perceived family reaction to the vaccine,
some believed that family members would be supportive for ‘‘it
is just a protection’’. Others anticipated family disapproval
because of their young age. One girl in group C said ‘‘They will
think that I am too young for sex and have no need for this
vaccine now’’. There were also concerns expressed about how
others might see them if people knew that the vaccine was for
the prevention of a sexually transmitted infection. ‘‘If my
family knows what this (HPV vaccine) is for and if I say I want
it, they would think that I am fooling around’’, said a girl in
group B.
Findings on knowledge, attitude and vaccination intention
Data obtained from the questionnaire are presented in table 2.
Attitudes and perceived support from family or peers correlated
significantly with the intention to be vaccinated and willingness
to conform. Mean scores of knowledge and attitudes, the
proportions of individuals having a positive intention to be
vaccinated and of those who were willing to conform to
significant others increased significantly after focus group
discussion (table 3). A summary of the findings are presented
in box 3.
DISCUSSION
The participants’ knowledge about cervical cancer was grossly
inadequate, whereas HPV was unheard of. The teenage girls had
difficulty understanding the nature of high-risk HPV infections
and the mechanisms leading to the development of cervical
cancer. Knowledge about HPV vaccination was piecemeal and
distorted. The knowledge inadequacy had been expected and
was similar to findings from other countries.6 11 The perceived
risk of HPV infection and cervical cancer was understandably
low because most participants were sexually inexperienced and
did not plan to engage in sex in the near future.
Participants have a generally favourable attitude towards
HPV vaccination. After the focus group, knowledge and attitude
scores, as well as the proportion of participants likely to be
vaccinated increased significantly, but no direct correlation
between knowledge and vaccination intention was found. The
small sample size of the study may have contributed to the
negative findings. The lack of immediate personal relevance of
cervical cancer and low intention to engage in sex in the near
future may override any other influences on vaccination
intention. The influence of knowledge on behavioural intention
is complex and inconclusive. What was presented and how it
Table 2 Correlations between knowledge, attitudes, perceived support of significant others and HPV
vaccination measured after focus group
Knowledge about
cervical cancer
and HPV infection
Attitudes
towards HPV
vaccination
Perceived family
support towards
vaccination
Perceived peer
support towards
vaccination
rs{ rs rs rs
Intention to be vaccinated now 20.170 0.448{ 0.555{ 0.349{
Willingness to conform to family’s decision 20.127 0.348{ 0.316* NA
Willingness to conform to peers’ decision 20.202 0.208 NA 0.526{
HPV, human papillomavirus; NA, not applicable.
*p(0.05. {rs, Spearman rank correlation coefficient. {p(0.01.
Table 3 Comparison of knowledge, attitudes, vaccination intention and willingness to conform before and
after the focus group
Before group After group p Value
Knowledge: mean (SD) 7.94 (2.26) 12.81 (1.39) ,0.001*
Attitudes: mean (SD) 20.31 (4.79) 21.53 (3.84) 0.011*
n (%) n (%)
Intention to be vaccinated now 0.013{
Very likely 2 (3) 3 (5)
Likely 29 (48) 41 (64)
Unlikely 26 (43) 18 (28)
Very unlikely 4 (7) 2 (3)
Willingness to conform to family 0.001{
Very willing 3 (5) 9 (14)
Willing 43 (72) 51 (80)
Unwilling 11 (18) 2 (3)
Very unwilling 3 (5) 2 (3)
Willingness to conform to peers 0.025{
Very willing 5 (8) 8 (13)
Willing 45 (75) 51 (80)
Unwilling 6 (10) 4 (6)
Very unwilling 4 (7) 1 (2)
*Obtained by paired t test. {Obtained by Wilcoxon signed ranks test.
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was presented by the facilitators could potentially bias
participants’ response towards vaccination. It is also plausible
that authoritative knowledge may have worked with other
factors to potentiate the participants’ acceptability of vaccina-
tion. This is especially so in a group setting, as in our study, in
which favourable peer responses and group pressure may
prompt the participants to accommodate to the group norm.
Positive endorsement from significant others and medical
professionals were noted to be facilitating factors to enhance
vaccine acceptability. The influence of others was notably
strong, as demonstrated by the fact that there were proportio-
nately more participants who were willing to conform to peers
or families than their own stated intention to be vaccinated.
This finding is consistent with the literature noting the strong
impact of peer and parental influences on adolescent sexual
behaviours.12 It is also likely that perceived negative family
endorsement of HPV vaccination may have an even stronger
influence than positive endorsement, particularly in view of the
fact that the teenage girls are still financially dependent.
Cost is a practical issue, which prompted the participants
to consider more stringently the right timing of vaccina-
tion, attempting to match the current known duration of
effectiveness of the HPV vaccine with their expected age of sexual
debut, which was relatively conservative in comparison with data
from the west.13 Such a consideration reflected the participants’
belief that sex was a planned and highly controllable act. This
belief, however, is challenged by findings indicating that
adolescent health-risk behaviour, such as engaging in unprotected
sex, is often unplanned and unintentional.14
Of interest to note was the anticipated family disapproval
against HPV vaccination by some participants. This was in
contrast to findings from another qualitative study in which
Chinese women were in favour of vaccinating their teenage
daughters but were worried that they could not persuade the
teenagers to be vaccinated.15 The potential encouragement of
early sex or promiscuity as a result of HPV vaccination was not
a significant concern among the mothers. To promote better
acceptability in the adolescent population, however, explicit
downplaying of any suspicion of sexual impropriety needs to be
communicated.
Implications
The findings indicate that there is a need to provide adolescent
girls with authoritative information on cervical cancer, HPV
infection and HPV vaccination to increase their understanding of
why action needs to be taken at their young age to prevent a
seemingly adult disease that would not happen in the immediate
future. Peer and family influences are important factors affecting
adolescents’ attitudes towards HPV vaccination. The promotion
of HPV vaccination may thus need to target both parents and the
adolescent social norm. Furthermore, strategies to foster commu-
nication between parents and adolescents on the issue of HPV
vaccination may help to clear up potential misunderstandings and
enhance vaccine uptake.
At present, little can be done to overcome the barriers of cost
and the uncertain duration of effectiveness of the vaccine on an
individual level. Educational and behavioural interventions may,
however, prompt adolescents to exercise caution against
unplanned and unprotected sex and increase their perceived
need to take preventive measures, including vaccination, against
HPV or other sexually transmitted infections.12 Indeed, a better
awareness of the potential hazards of unprotected sex may even
discourage sexual experimentation in the youth population. On
the public health level, although it has been recommended that
young adolescents should be vaccinated at the age of 12 years or
younger based on the expected age of sexual debut in the west,16
the situation in Asia may be different as a result of a later onset
age of sex in general.17 Therefore, in recommending an optimal
timing for HPV vaccination, there needs to be a realistic
consideration of individual and sociocultural differences in
sexual attitudes and behaviours, the preparedness for sexual
ventures and socioeconomic issues.
The qualitative nature of the study in which quantification
and representativeness were not the objectives inevitably
imposes limitations on the findings. In particular, the sample
size was small, the participants were not meant to be
representative and no causal inferences could be established.
Despite this, the findings provide a good basis for further large-
scale studies of a more quantitative nature to be planned.
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Key messages
c Adolescent girls’ knowledge about cervical cancer, HPV
infection and HPV vaccination was grossly inadequate and
misconceptions abound.
c HPV vaccination was viewed favourably by most of the girls.
In general, however, there was no immediate perceived need
for HPV vaccination as a consequence of the monetary cost,
the uncertain duration of effectiveness of the vaccines and
their not planning to engage in sex in the near future. The
perceived timing of vaccination was largely determined by
participant’s intended age of sexual debut.
c Focus can be directed towards developing educational and
behavioural interventions for adolescents to guard against
unplanned and unprotected sex and to increase their perceived
need to take preventive measures, including vaccination,
against HPV or other sexually transmitted infections.
Box 3: Perceptions and factors associated with the
acceptability of HPV vaccination among the participants
General attitude
c Favourable with varied views on the timing of vaccination
Barriers
c High monetary cost
c Uncertain length of vaccine effectiveness
c Low perceived risk of HPV infection because not engaging in
sex at present
c No immediate perceived need because of slim chance of
having sex in the near future
c Anticipated family disapproval
c Fear of the pain of injection
Facilitators
c Family support
c Peer support
c Medical reassurance on safety and efficacy of vaccine.
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